• Font Size:
  • A
  • A
Healthcare Professionals  questions in your Checklist | Register
IMPORTANT SAFETY INFORMATION

BETASERON® (interferon beta-1b) should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites...continue reading below

Could BETASERON® be right for me?

Patient 2 (Regina)
I travel a lot, so I need a therapy that's easy to take on trips.

It's important to find a RRMS treatment that's effective—and fits your needs. BETASERON is proven to help delay the onset of CDMS in patients with clinically isolated syndrome (CIS).8 BETASERON also offers features that may make it the right therapy for you:

  • Every-other-day dosing
  • One of the thinnest needles available (30 gauge) in MS treatment
  • Convenient, refrigeration-free storage for traveling*
  • BETAPLUS®, the MS support program that offers 24/7 BETA Nurse access, copay assistance and a variety of helpful tools and information

Need help talking to your healthcare team about MS therapy?

Check out "BETASERON Because" Doctor Discussion Checklist.

GO


*BETASERON is the only injectable immunomodulatory MS therapy that can be stored at room temperature until its expiration date and before reconstitution. If not used immediately after reconstitution, the product should be refrigerated and used within 3 hours.

INDICATIONS AND USAGE

BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

IMPORTANT SAFETY INFORMATION

  • BETASERON should be used with caution in patients with depression.
  • Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites.
  • Severe hepatic injury, including cases of hepatic failure, has been reported. Patients should be monitored for liver enzyme elevations while taking BETASERON.
  • BETASERON should be used with caution in patients with seizure disorders or cardiac disease.
  • Female patients should be warned about the potential risk to pregnancy.
  • Cases of anaphylaxis have been reported rarely.
  • The most commonly reported adverse reactions are lymphopenia (low numbers of a certain kind of white blood cell), Injection-site reaction, asthenia (general weakness), flu-like symptom complex (flu syndrome and/or a combination of at least two Adverse Events from fever, chills, muscle aches, tiredness and sweating), headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms.

See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.

For important risk and use information, please see the full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.